| Document |
Document Title |
|
WO/2024/021544A1 |
The present invention provides use of vitamin C lactate and analogs thereof in the preparation of articles of manufacture for skin tissue, and related articles of manufacture thereof. The vitamin C lactate and the analogs thereof of the ...
|
|
WO/2024/024565A1 |
The present invention addresses the problem of providing an agent that suppresses cell aging and a drug that prevents or treats diseases and the like caused by cell aging. More specifically, the present invention is a cell aging suppress...
|
|
WO/2024/023715A1 |
The present invention relates to a topical composition comprising a cannabinoid, extracellular matrix component or extracellular matrix fragment, such as an extracellular polysaccharide that is hyaluronic acid, and a pharmaceutically acc...
|
|
WO/2024/023440A1 |
The present invention relates to the novel cosmetic use of a Gentiana crassicaulis extract and/or of a composition comprising same for the cosmetic treatment and/or cosmetic care of healthy skin and/or mucosae selected from skin and/or m...
|
|
WO/2024/026365A1 |
Described herein are topical cream formulations that include a C7–20 alkane, a metal chelating agent, and a buffer.
|
|
WO/2024/024765A1 |
The purpose of the present invention is to provide a multilayer object which has excellent handleability during application to adherends and excellent durability in a dry state and in which the outermost layers on both sides do not diffe...
|
|
WO/2023/220748A9 |
Endoscopic surgery targeted at the sinuses and nasal turbinates assists in managing the symptoms of chronic rhinosinusitis and other conditions. With contemporary techniques, post-operative hemorrhage, synechiae formation and poor wound ...
|
|
WO/2024/023727A1 |
A compound having the structures: Formulae (Ia) or (Ib) or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein; R selected from the group cons...
|
|
WO/2024/024915A1 |
Provided is a technique for preventing or treating a periostin-mediated disease and pruritus associated with the disease. The present invention relates to, for example, a prophylactic or therapeutic agent for a periostin-mediated disease...
|
|
WO/2024/023192A1 |
The present invention generally relates to the field of skin care. More particularly, the invention relates to a cosmetic or therapeutic skin care composition comprising at least one skin-health promoting Staphylococcus strain that exert...
|
|
WO/2024/021143A1 |
Disclosed is use of levocetirizine or a pharmaceutically acceptable salt thereof in preparing a medicament for promoting hair growth. The present invention relates to the field of biopharmaceuticals. Research has found that levocetirizin...
|
|
WO/2023/234788A9 |
The present invention relates to a method for the treatment of wounds and/or infections associated with diabetes mellitus or hypoxia, diabetic foot ulcers and/or gangrene, as well as any wound caused by pathogenic microorganisms, said me...
|
|
WO/2024/023190A1 |
The present invention generally relates to the field of skin care. More particularly, the invention relates to a cosmetic or therapeutic skin care composition comprising at least one of the skin-health promoting Staphylococcus strains se...
|
|
WO/2024/022890A1 |
The invention relates to a muscle membrane intended to be affixed to a muscle of a human or animal body, the membrane being capable of at least partially surrounding the muscle, the muscle comprising fibres covered with an outer tissue, ...
|
|
WO/2024/019596A1 |
The present invention relates to a sustained-release formulation containing a 5-alpha-reductase inhibitor, and can be used for the prevention, amelioration, or treatment of prostatic hyperplasia and alopecia.
|
|
WO/2024/020598A1 |
Provided herein are methods of treating nalbuphine-treatable disorders in an elderly patient.
|
|
WO/2024/017880A1 |
A series of substituted imidazo[l,2-b][l,2,4]triazine derivatives of Formula (I) as defined herein, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments,...
|
|
WO/2024/017331A1 |
The present invention belongs to the fields of bioengineering and biological treatment. Disclosed are an anti-ADM monoclonal antibody or a fragment thereof and a pharmaceutical composition, a detection reagent, or a kit comprising the mo...
|
|
WO/2024/018955A1 |
The present invention addresses the problem of providing an oral composition which contains ergothioneine or a salt thereof and a glucosamine compound and yet in which the bitterness derived from ergothioneine or the salt thereof and the...
|
|
WO/2024/020170A1 |
Provided herein are compounds which can act agonists of the aryl hydrocarbon receptor (AHR). Further disclosed herein are methods for treating inflammatory and autoimmune diseases and disorders, such as diseases or disorders of the gastr...
|
|
WO/2024/019495A1 |
The present invention relates to a pharmaceutical composition for treating or preventing atopic dermatitis, the pharmaceutical composition comprising iCP-NI. The pharmaceutical composition makes it possible to administer iCP-NI, previous...
|
|
WO/2024/019661A1 |
The present disclosure concerns a method of promoting the ubiquitination of MK2 protein, comprising contacting the MK2 protein with a compound of Formula (I) or a salt, solvate, stereoisomer or prodrug thereof. The present disclosure als...
|
|
WO/2024/017227A1 |
Provided is a cannabinoid receptor compound as represented by formula I. The compound has a good ability to bind to the human CB2 receptor, and exhibits good agonistic activity and high selectivity on the CB2 receptor. Consequently, said...
|
|
WO/2024/017804A1 |
The present invention relates to hydrogels that are suitable for medical use, more particularly in the dressing of wounds. The hydrogels contain a metal complex as active ingredient and lead to an excellent antimicrobial effect against b...
|
|
WO/2024/018160A1 |
Disclosed is the use of an anhydrous extract of stemless leaves of Hippophae rhamnoides or a cosmetic composition comprising said extract for use in reducing circles and/or pockets at the contour of the eye and/or in maintaining and/or p...
|
|
WO/2024/016640A1 |
The present invention relates to an antihistamine compound, and a preparation method therefor and the use thereof. Specifically, the present invention relates to an antihistamine compound having a structure of formula I and a pharmaceuti...
|
|
WO/2024/018956A1 |
The present invention addresses the problem of providing an oral composition in which bitterness originating from ergothioneine or a salt thereof and an odor originating from chondroitin sulfate or a salt thereof are suppressed despite t...
|
|
WO/2024/020135A1 |
An in vitro method of quantifying an estimated dosage of at least one endogenous component from a human placental membrane allograft to a subject in need thereof in vivo during a predetermined time period.
|
|
WO/2024/011599A1 |
A use of a composition in preparation of a medicament for burn wound therapy is provided, wherein the composition comprises an effective amount of mangosteen fruit shell extract.
|
|
WO/2024/012387A1 |
A use of a composition comprising an Artemisia annua extract and a water-soluble component in fighting skin allergies, inflammation, and/or irritation, and a use in the preparation of a dermatological topical agent for fighting skin alle...
|
|
WO/2024/014663A1 |
The present invention relates to a pharmaceutical composition, a food composition, and a cosmetic composition for preventing or treating alopecia, the composition comprising, as an active ingredient, an Akkermansia sp. strain, vesicles o...
|
|
WO/2024/011868A1 |
The present invention relates to the technical field of medicines. Disclosed is a use of vanillyl butyl ether in the preparation of products for treating dandruff and tinea corporis. The present invention provides the use of vanillyl but...
|
|
WO/2024/012291A1 |
A composition for improving the efficacy of a hair growth active substance and a preparation method therefor, wherein the composition comprises a stabilizer, a pharmaceutically acceptable carrier, and lipophilic particles suspended in th...
|
|
WO/2024/014882A1 |
The present invention relates to: a Bacillus coagulans PA strain for producing a large amount of polyamine; and a polyamine preparation method using same. The Bacillus coagulans PA strain of the present invention proliferates in anaerobi...
|
|
WO/2024/013741A1 |
Provided herein a topical cream composition comprising tapinarof or a pharmaceutically acceptable salt thereof and uses thereof for treating skin disorders.
|
|
WO/2024/014795A1 |
The present invention relates to: a method for producing a hydrogel prepared from an extracellular matrix without a separate polymer support or a hydrogel precursor solution; a hydrogel produced therefrom; a sponge produced by freeze-dry...
|
|
WO/2024/012534A1 |
Provided are heterocyclic fused benzene ring compounds, a preparation method therefor, and the use thereof. The heterocyclic fused benzene ring compounds are heterocyclic compounds represented by formula I, tautomers thereof, stereoisome...
|
|
WO/2024/013622A1 |
The present invention relates to a method for obtaining an umbilical cord extract that can be used for tissue regeneration or repair, for medical or cosmetic uses, as a preparation base for liquid, semisolid or solid grafts or dressings,...
|
|
WO/2024/015597A1 |
This disclosure relates to compositions for treating skin conditions and improving skin health. In particular, the disclosure relates to compositions formulated as an absorbent article to be topically applied to skin, the absorbent artic...
|
|
WO/2024/013283A1 |
The invention relates to a composition suitable for topical administration, comprising brimonidine or salts thereof, for use thereof in the prevention and treatment of skin damage resulting from radiation selected from ultraviolet (UV) r...
|
|
WO/2024/012021A1 |
The present invention relates to the technical field of proteolysis-targeting chimerias (PROTACs). Disclosed are a PROTAC molecule and a preparation method therefor and a use thereof. A target protein ligand in the PROTAC molecule of the...
|
|
WO/2024/015095A1 |
A method, and formulations for the method, for the treatment of skin pigmentation issues is herein described. Typically, the method involves applying an exosome-based skincare product to skin affected by skin pigmentation issues. The exo...
|
|
WO/2024/014624A1 |
The present invention relates to a photothermal microneedle patch containing gold nanoparticles. The patch of the present invention is a patch in which a skin-soluble microneedle containing a drug or a cosmetic composition is formed on a...
|
|
WO/2024/012425A1 |
The present invention relates to a compound, a pharmaceutical composition containing same, a preparation method therefor, and the use thereof as an RIPK1 inhibitor. The compound is a compound as represented by formula (I), or an optical ...
|
|
WO/2024/012400A1 |
The present invention relates to a tretinoin alcohol-amine compound, which consists of tretinoin and an alcohol-amine compound, is liquid at normal temperature, has good water solubility/water dilution resistance and skin permeation effe...
|
|
WO/2024/011946A1 |
Provided is a polypeptide dimer for the treatment of systemic sclerosis.
|
|
WO/2024/012386A1 |
The present invention provides a use of a composition containing an Artemisia annua L. extract and an oil-soluble component in skin anti-allergy, anti-inflammation and/or anti-irritation, wherein the oil-soluble component is selected fro...
|
|
WO/2024/012787A1 |
The present invention relates to an extract of the leaves of Jasminum sambac comprising iridoid glycosides comprising sambacoside A and at least two molihuasides, a composition comprising such extract and uses thereof. Furthermore, the p...
|
|
WO/2024/012385A1 |
Provided is the use of a composition comprising an Artemisiae annuae herba extract and a functional active substance in combating skin allergies, skin inflammation and/or skin irritation, wherein the functional active substance is select...
|
|
WO/2024/016002A1 |
Described herein are milk exosomes and uses thereof. In some embodiments, the milk exosomes are capable of targeting an injury site or a cancer cell or population thereof. The milk exosomes can contain an exogenous cargo. Described herei...
|
